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In Brief
Long-term hematopoietic stem cells
(LT-HSCs) are activated by recombinant
type I interferon (IFN-I). Hirche et al. report
here that acute systemic virus infections
activate LT-HSCs independently of IFN-I
receptor signaling. Non-acute infection of
bone marrow donors impacts LT-HSC
function, but not phenotype, potentially
explaining clinical complications
following bone marrow transplantations.
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Quiescent long-term hematopoietic stem cells (LT-
HSCs) are efficiently activated by type I interferon
(IFN-I). However, this effect remains poorly investi-
gated in the context of IFN-I-inducing virus infec-
tions. Here we report that both vesicular stomatitis
virus (VSV) and murine cytomegalovirus (MCMV)
infection induce LT-HSC activation that substantially
differs from the effects triggered upon injection of
synthetic IFN-I-inducing agents. In both infections,
inflammatory responses had to exceed local thresh-
olds within the bone marrow to confer LT-HSC cell
cycle entry, and IFN-I receptor triggeringwas not crit-
ical for this activation. After resolution of acuteMCMV
infection, LT-HSCs returned to phenotypic quies-
cence. However, non-acute MCMV infection induced
a sustained inflammatory milieu within the bone
marrow that was associated with long-lasting impair-
ment of LT-HSC function. In conclusion, our results
show that systemic virus infections fundamentally
affect LT-HSCs and that also non-acute inflammatory
stimuli in bone marrow donors can affect the recon-
stitution potential of bone marrow transplants.
INTRODUCTION
A scarce population of long-term hematopoietic stem cells (LT-
HSCs) is responsible for lifelong blood and immune cell genera-Cel
This is an open access article under the CC BY-Ntion (Morrison and Weissman, 1994). LT-HSCs reside in defined
spatial and microenvironmental bone marrow niches (Morrison
and Scadden, 2014), and they maintain a predominantly quies-
cent cell cycle state (Wilson et al., 2007). However, upon he-
matopoietic stress, such as blood loss, chemotherapy, anemia,
or bone marrow aplasia, LT-HSC activation ensures efficient
replenishment of blood and immune cells (Wilson et al., 2008).
Recently, inflammatory responses induced by Toll-like recep-
tor (TLR) ligands (Nagai et al., 2006; Takizawa et al., 2011), most
notably the synthetic RNA polyinosinic:polycytidylic acid
(poly(I:C)) (Essers et al., 2009; Haas et al., 2015), were shown
to induce cell cycle activation and differentiation of LT-HSCs.
Poly(I:C) is a potent inducer of a type I interferon (IFN-I)-biased
inflammatory response. IFN-I is triggered early upon virus infec-
tion and plays a pivotal role in establishing an anti-viral state and
promoting immune cell-mediated virus clearance (Crouse et al.,
2015). Importantly, the poly(I:C)-mediated cell cycle induction of
LT-HSCs was shown to be mainly driven in an IFN-I receptor
(IFNAR)- and STAT1-dependent manner (Essers et al., 2009).
After poly(I:C)-mediated activation, LT-HSCs return to quies-
cence and, thus, avoid apoptosis and DNA damage (Pietras
et al., 2014; Walter et al., 2015). Similar to IFN-I, also IFN-II
(IFN-g) has been linked to HSC activation (Baldridge et al.,
2010), and particularly it triggers the differentiation of myeloid
HSCs (Matatall et al., 2014).
Collectively, studies suggest that IFN-I induced upon injection
of synthetic TLR ligands or injected as recombinant cytokine
triggers LT-HSC cell cycle activation. Although of fundamental
clinical importance, the effects of live, IFN-I-inducing viruses
on LT-HSCs have not been intensively studied. Especially immu-
nosuppressed bone marrow transplant patients are at enhancedl Reports 19, 2345–2356, June 13, 2017 ª 2017 The Authors. 2345
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
risk of severe infections with opportunistic pathogens, such as
the obligatory human-specific b-herpesvirus cytomegalovirus
(HCMV). In immunocompetent individuals primary HCMV infec-
tion is usually asymptomatic. However, in immunocompromised
patients, the virus causes severe disease (Boeckh and Nichols,
2004), and acute HCMV viremia can even elicit graft rejection
in bone marrow-transplanted patients (Fries et al., 2005).
Here we studied whether acute or non-acute virus infections
induce inflammatory responses that would confer LT-HSC
activation and affect their reconstitution potential. Our results
indicate that peripheral virus infections induce inflammatory
responses in blood and bone marrow that are capable of medi-
ating LT-HSC cell cycle entry. Notably, this LT-HSC activation
occurs largely independent of IFNAR signaling. Moreover, we
show that acute virus infection impairs the reconstitution po-
tential of LT-HSCs and that, even after resolution of acute virus
infection and return to phenotypical quiescence, LT-HSCs
continue to show a reduced reconstitution potential. Thus,
our results establish a link between non-acute systemic infec-
tions of bone marrow donors and complications in transplant
recipients.
RESULTS
High-Dose Virus Challenge or Uncontrolled Viral
Replication Is Required for VSV-Induced Cell Cycle
Activation of LT-HSCs
To investigate the impact of virus-induced IFN-I on LT-HSCs,
wild-type (WT) and IFN-I receptor-deficient mice (IFNAR/)
were infected with vesicular stomatitis virus M2 (VSV). This virus
lacks the immunomodulatory function of the M encoding
gene (Stojdl et al., 2003), and, hence, it induces particularly
strong IFN-I responses (Waibler et al., 2007). To analyze
LKCD150+CD48CD34 LT-HSCs, lineagec-Kit+ (LK) bone
marrow was stained for signaling lymphocyte activation markers
(SLAMs) (Kiel et al., 2005) and CD34 (Osawa et al., 1996) (see
Figure S1A and Haas et al., 2015 for fluorescence-activated
cell sorting [FACS] gating strategy). Cell cycle status was
determined 1 day post-infection (dpi) by Ki-67/Hoechst staining.
As reported previously, treatment of WT mice with the synthetic
RNA poly(I:C) resulted in cell cycle activation (G1-S-G2-M) of
quiescent (G0) LT-HSCs. Furthermore, LT-HSC activation was
significantly reduced in IFNAR/mice, indicating that poly(I:C)-
induced IFN-I responses were critical (Figure 1A; Essers et al.,
2009).
To investigate whether systemic infection with live viruses
would also trigger IFNAR-dependent activation of LT-HSCs,
we infected mice with 1 3 105 plaque-forming units (PFUs)
VSV (VSV int). Surprisingly, this dose did not trigger LT-HSC
cell cycle activation in WT but in IFNAR/ mice (Figure 1A). Of
note, quantification of peripheral virus loads revealed that, unlike
in immunocompetent WT mice, IFNAR/ mice showed uncon-
trolled virus replication and LT-HSC activation (Figure 1B). In
both WT and IFNAR/ mice, VSV infection induced leukopenia
1 dpi (Figure S1B). However, while WT mice recovered by 2 dpi,
IFNAR/mice rapidly succumbed to the infection (Figure S1C).
Although WT LT-HSCs did not respond to VSV int infection,
infection of WT mice with a higher dose of 1 3 107 PFUs (VSV2346 Cell Reports 19, 2345–2356, June 13, 2017hi) efficiently triggered transient LT-HSC activation (Figures 1C
and S1D).
Next, we investigated the induction of IFN-a in blood and bone
marrow during VSV infection. While VSV int infection of WT mice
resulted in moderate IFN-I responses within the bone marrow,
VSV hi induced substantial IFN-a levels, comparable with those
observed upon poly(I:C) treatment (Figures 1D and S1E). This
suggested that moderate IFN-I responses induced upon VSV
int infection did not suffice to trigger LT-HSC cell cycle activa-
tion. To further study direct IFNAR triggering of LT-HSCs, we
used MxCre+Rosa26eYFPST/ST mice that express a yellow fluo-
rescent protein (YFP) reporter under the control of the IFN-I-stim-
ulated Mx gene. Indeed, VSV int infection did not induce YFP
expression in LT-HSCs, whereas VSV hi infection conferred
enhanced YFP expression in LT-HSCs and the overall bone
marrow (Figure 1E). Thus, VSV int infection of the immunocom-
petent host induces only moderate IFN-I responses that do not
suffice to activate LT-HSCs, whereas VSV hi infection induces
substantial IFN-I responses in the bone marrow that trigger
HSC cell cycle entry. In contrast, in the immunocompromised
host with uncontrolled virus replication, VSV int infection already
leads to IFNAR-independent LT-HSC activation.
Upon Murine Cytomegalovirus Infection, LT-HSCs Are
Activated in a Combination of IFNAR-Dependent and
-Independent Pathways
To study an infection with high relevance for clinical bone
marrow transplantation, we performed experiments with murine
cytomegalovirus (MCMV), which shows more than 90%
sequence homology with human CMV. We used an MCMV
variant (Jordan et al., 2011) lacking the crucial natural killer
(NK) cell receptor ligand m157 (Arase et al., 2002). This virus is
less efficiently cleared and causes productive infection in
C57BL/6 mice (Mitrovic et al., 2012).
Upon infection with 5 3 105 PFUs MCMV, WT mice showed
transient weight loss and survived, whereas IFNAR/mice suc-
cumbed to the infection (Figures S2A and S2B). Of note, no
peripheral blood leukopenia was detected (Figure S2C). Never-
theless, MCMV infection of WT and IFNAR/ mice resulted in
massive bone marrow aplasia as well as reduced LT-HSC
numbers (Figures 2A and S2D), and LT-HSCs entered the cell
cycle by 4 dpi (Figure 2B). Interestingly, LT-HSC cell cycle entry
was more pronounced in MCMV-infected WT mice than in
IFNAR/ mice (Figures 2B and S2E), suggesting that IFNAR-
dependent and -independent pathways had additive effects on
LT-HSC activation. Similar to VSV infection, alsoMCMV-infected
IFNAR/ mice showed significantly higher virus burden in pe-
ripheral organs (Figure 2C) and bone marrow than WT mice
(Figure S2F).
Next, we investigated the IFN-a induction in blood and
bone marrow during MCMV infection. While in MCMV-infected
WT mice only slightly elevated serum IFN-a levels were de-
tected by 1 dpi (Figure S2G), bone marrow IFN-a levels were
significantly increased 1 and 4 dpi (Figure 2D). Accordingly,
MCMV-infectedMxCre+Rosa26eYFPST/ST reporter mice showed
enhanced percentages of YFP expression in LT-HSCs and other
bone marrow cells (Figure 2E), indicating direct IFNAR triggering
of LT-HSCs upon MCMV infection. Thus, MCMV efficiently
Figure 1. Challenge with High-Virus Dose or
Uncontrolled Viral Replication Is Required
for VSV-Induced Cell Cycle Activation of
LT-HSCs
(A) Intracellular Ki-67/Hoechst staining for quies-
cent (G0) and activated (G1-S-G2-M) LT-HSCs of
WT and IFNAR/ mice injected i.v. with either
10 mg/g poly(I:C) or 1 3 105 PFUs VSV 1 dpi (n =
8–14; N = 3). Percentages in flow cytometry blots
represent cells in G0.
(B) Correlation of peripheral virus titer (determined
by plaque assay in spleen, left y axis) and activated
(G1-S-G2-M) LT-HSCs (rights y axis) of WT and
IFNAR/ mice infected i.v. with either 1 3 105
PFUs VSV (VSV int) or 1 3 107 PFUs VSV (VSV hi)
1 dpi (n = 6–14; N = 2–3). Crosses indicate mice
succumbing to infection.
(C) LT-HSC activation kinetics at indicated dpi of
WT mice infected with either VSV int or VSV hi (n =
4–9; N = 2).
(D) IFN-a ELISA of bone marrow supernatants of
mice from (A)–(C) (n = 6; N = 2). Red boxes below
graph indicate coinciding LT-HSC responses (exit
from quiescence). Black crosses indicate mice
succumbing to infection.
(E) Percentage YFP+ LT-HSCs, total bone marrow,
and splenocytes of MxCre+Rosa26eYFPST/ST mice
1 dpi with either VSV int or VSV hi (n = 5–6; N = 2).
Error bars indicate mean ± SD; significance was
determined by two-sided t test or two-way ANOVA
(*p % 0.05, **p % 0.0025, and ***p % 0.0001; ns,
not significant; n, biological replicates; N, experi-
mental repetitions).
See also Figure S1.induces LT-HSC activation, even at an intermediate infection
dose, by a combination of IFNAR-dependent and -independent
pathways.
Upon Peripheral Virus Infection, LT-HSC Activation Is
Conferred by Inflammatory Cytokine and Chemokine
Responses in the Bone Marrow
The above data indicated that, upon VSV and MCMV infection,
other signaling pathways may confer LT-HSC activation in addi-
tion to IFNAR triggering. To further characterize the corresponding
inflammatory responses, we performed cytokine and chemokine
arrays in serum and bone marrow of VSV- and MCMV-infected
mice. VSV int infection induced a diverse inflammatory response
in the serum of WT and IFNAR/ mice. However, in the bone
marrow of WT mice, the response was strongly attenuated
when compared with IFNAR/ mice (Figure 3A). Interestingly,
only upon conditions that triggered LT-HSC activation (VSV hiCell Rinfection of WT mice or VSV int infection
of IFNAR/ mice) were inflammatory re-
sponses detected within the bone marrow
that included significantly increased levels
of IL-10, IL-12(p40), CCL2, CCL3, and
CCL4 (Figures 3A–3C). In silico analysis
of published transcriptome data (Cabe-
zas-Wallscheid et al., 2014) suggestedexpression of the respective cytokine and chemokine receptors
on LT-HSCs, with particularly high expression of IL-10 and IL-12
receptors (Figure S3A). FACS analysis confirmed the expression
of IL-10 receptor on LT-HSCs, and it showed an increased
receptor expression during VSV hi infection (Figure S3B). These
data support the hypothesis that the cytokines detected in the
bone marrow of VSV-infected mice might directly act on
LT-HSCs.
In comparison to VSV, MCMV infection of WT and IFNAR/
mice caused significantly different inflammatory responses in
blood and bone marrow (Figure 3D). Nevertheless, also MCMV
infection induced IL-10, IL-12(p40), CCL2, CCL3, and CCL4
within the bone marrow of WT and IFNAR/ mice at the time
when LT-HSC activation was detected (Figures 3D and 3E).
Thus, upon VSV as well as MCMV infection, bone marrow
expression of distinct cytokines and chemokines correlates
with LT-HSC activation.eports 19, 2345–2356, June 13, 2017 2347
Figure 2. MCMV Infection Induces IFNAR-Independent Bone Marrow Aplasia and Readily Activates LT-HSCs
(A) Hind leg bones (hip bone, femur, tibia) of WT and IFNAR/mice 4 dpi with 53 105 PFUsMCMV i.v. (left panel). Total bone marrow cell count of infected mice
1 and 4 dpi is shown (right panel; n = 4–10; N = 2).
(B) Intracellular Ki-67/Hoechst staining for quiescent (G0) and activated (G1-S-G2-M) LT-HSCs 1 and 4 dpi of MCMV-infected WT and IFNAR
/ mice (n = 5–9;
N = 3). Percentages in flow cytometry blots represent cells in G0.
(C) Correlation of peripheral virus titer (determined by plaque assay in liver, left y axis) and activated (G1-S-G2-M) LT-HSCs (rights y axis) ofWT and IFNAR
/mice
1 or 4 dpi with MCMV (n = 5–9; N = 2–3).
(D) IFN-a ELISA of bone marrow supernatants of mice from (B) and (C) (n = 6–13; N = 2). Red boxes below graph indicate coinciding LT-HSC responses (exit from
quiescence).
(E) Percentage YFP+ LT-HSCs, total bone marrow, and splenocytes of MxCre+Rosa26eYFPST/ST mice 1 and 4 dpi with MCMV (n = 5–6; N = 2). Error bars indicate
mean ± SD; significance was determined by two-sided t test or two-way ANOVA (*p% 0.05, **p% 0.0025, and ***p% 0.0001; ns, not significant; n, biological
replicates; N, experimental repetitions).
See also Figure S2.Acute and Non-acute MCMV Infection of Mice Impairs
Bone Marrow Reconstitution Capacity
To test whether virus-induced LT-HSC activation affects their
reconstitution potential, we performed competitive bonemarrow
transplantation experiments with bone marrow from MCMV-in-
fected mice. Since CMV has the potential to establish persistent
infection (Pollock et al., 1997), we studied bone marrow isolated
during the acute (4 dpi) and a non-acute phase of infection
(21 dpi).
CD45.2+ WT mice were either PBS treated or MCMV infected,
bonemarrow was isolated at 4 or 21 dpi, mixed at a 1:1 ratio with
CD45.1+ WT control bone marrow of untreated animals (Fig-
ure S4A), and a total of 1 3 106 cells were transplanted into
lethally irradiated CD45.1+ WT recipients (Figure 4A). While
bone marrow derived from PBS-treated controls showed similar
reconstitution as bone marrow from untreated animals, bone
marrow isolated 4 dpi with MCMV (4-dpi bone marrow) showed
severely reduced reconstitution of all analyzed immune cell
subsets up to 12 weeks post-transplantation (p.t.) (Figures 4B2348 Cell Reports 19, 2345–2356, June 13, 2017and 4C). Both these experimental groups showed similar total
blood cell counts (Figure S4B), indicating that the reduced
engraftment of 4-dpi bone marrow was compensated by
untreated CD45.1+ control bone marrow. To investigate whether
the observed reconstitution deficits were due to impaired
LT-HSC function, we performed secondary transplantations af-
ter 12 weeks. Since other bone marrow compartments do not
retain their reconstitution capacity during secondary transplan-
tation, all newly formed blood cells in these experiments were
LT-HSC derived (Morrison and Weissman, 1994). In this setting,
4-dpi bone marrow still showed significantly reduced reconstitu-
tion of immune cell subsets (Figure 4D), indicating that acute
MCMV infection impaired LT-HSC function.
Bone marrow prepared from MCMV-infected mice 21 dpi
(21-dpi bone marrow) and transplanted at a 1:1 ratio with
CD45.1+ WT control bone marrow from untreated mice (Fig-
ure S4C) also showed significantly reduced reconstitution up
to 4 weeks p.t. compared with PBS-treated controls (Fig-
ure 4E). Also here, both experimental groups showed similar
Figure 3. LT-HSC Activation upon Systemic Virus Infection Is Mediated by Inflammatory Cytokine and Chemokine Responses in the Bone
Marrow
(A) Heatmaps of multiplex array for 22 cytokines and chemokines in blood sera and bone marrow supernatants of mice from Figure 1A (n = 3; N = 1).
(B) Heatmaps of multiplex array for 22 cytokines and chemokines in blood sera and bone marrow supernatants of mice from Figure 1C (n = 3; N = 1).
(C) Absolute values of cytokine and chemokine patterns identified in (A) and (B).
(D) Heatmaps of multiplex array for 22 cytokines and chemokines in blood sera and bone marrow supernatants of mice from Figure 2B (n = 3; N = 1).
(E) Absolute expression values of cytokine and chemokine patterns identified in (D). Red boxes next to heatmaps indicate coinciding LT-HSC responses (exit from
quiescence). Data were normalized toWTPBS controls. Error bars indicate mean ±SD; significancewas determined by two-sided t test (*p% 0.05, **p% 0.0025,
and ***p% 0.0001; ns, not significant; n, biological replicates; N, experimental repetitions).
See also Figure S3.total blood cell counts (Figure S4D), indicating that the
reduced engraftment of 21-dpi bone marrow was compen-
sated by untreated CD45.1+ control bone marrow. Upon sec-
ondary transplantation, the repopulation capacity of 21-dpi
bone marrow was still impaired during the initial 4 weeks (Fig-
ure 4G). Interestingly, lymphoid output was reduced for even
up to 8 weeks p.t. (Figure 4F). This was associated with both
a relative and absolute increase of phenotypically myeloid-
biased CD150hi HSCs (Beerman et al., 2010) in the bone
marrow of MCMV-infected mice 21 dpi (Figure 4H). Impor-
tantly, bone marrow isolated 4 months post-MCMV infection
no longer showed functional deficits (Figures S4E and S4F).
In summary, acute as well as non-acute MCMV infection re-
sults in long-term, but not infinitely lasting, improper reconsti-
tution following transplantation.Intrinsically Impaired LT-HSCs Are the Cause of Bone
Marrow Reconstitution Deficiencies following Acute
and Non-acute MCMV Infection
To further confirm that impaired LT-HSCswere indeed the cause
of improper reconstitution, competitive bone marrow chimeras
were generated with sorted lineage c-Kit CD150+CD48
(LKSLAM) HSCs from CD45.2+ donors of the respective PBS-
treated or MCMV-infected (4- and 21-dpi) groups. Bone marrow
mixtures of 500 CD45.2+ WT LKSLAM HSCs and 5 3 105
CD45.1+ WT control bone marrow (Figure S5A) were trans-
planted into lethally irradiated CD45.1+WT recipients (Figure 5A).
Strikingly, while by week 12 p.t. HSCs from PBS-treated mice
already gave rise to nearly half of all blood cells, 4- as well as
21-dpi HSCs showed significantly reduced reconstitution (Fig-
ures 5B and 5C). Nevertheless, all experimental groups showedCell Reports 19, 2345–2356, June 13, 2017 2349
Figure 4. Bone Marrow from Mice with Acute or Non-acute MCMV
Infection Shows Impaired Reconstitution Capacity
(A) Generation of competitive bone marrow chimeras and experimental layout.
(B) Total blood chimerism post-transplantation from donors 4 dpi with 53 105
PFUs MCMV i.v. (n = 7–10; N = 2).
(C) Percentage CD45.2+ cells in lymphoid (B220+ and CD3+) and myeloid
(Ly6/G+ and CD11b+) lineages post-transplantation from (A) (n = 7–10;
N = 2).
(D) Second transplant of bone marrow from mice from (B), blood chimerism
post-transplantation (n = 7–8; N = 2).
2350 Cell Reports 19, 2345–2356, June 13, 2017similar total blood cell counts (Figure S5B), indicating that the
reduced engraftment of 4- and 21-dpi HSCs was compensated
by untreated CD45.1+ control bone marrow. Comparable with
total bone marrow transplantations, 4- as well as 21-dpi HSCs
showed impaired reconstitution of immune cell lineages (Fig-
ure S5C). These data confirm that acute as well as non-acute
MCMV infection of donors causes intrinsic functional LT-HSC
impairment.
Non-acuteMCMV Infection Is Associatedwith Sustained
Changes in the Bone Marrow Milieu and in the LT-HSC
Gene Expression Profile
To elucidate the molecular basis of LT-HSC impairment during
non-acute MCMV infection, we thoroughly characterized WT
mice 21 dpi. At this time point, no infectious virus particles
were detected within the bone marrow (Figure S6A), while
peripheral viral titers were comparable with those detected
during the acute phase of the infection (4 dpi) (Figure S6B). To
study whether traces of virus were nonetheless present in
different bone marrow cell subsets, we performed highly sensi-
tive qRT-PCR analyses for the most abundant MCMV tran-
script,Mat (Juranic Lisnic et al., 2013). These analyses revealed
moderately elevated Mat expression in CD45 bone marrow
stroma, LKCD150 committed progenitors (CPs), and
LKCD150+CD48 HSCs (LKSLAM HSCs) from MCMV-infected
WT mice on 4 dpi, whereas Mat expression was no longer
detectable by 21 dpi (Figure 6A). As expected, highMat expres-
sion levels were detected in the same cell subsets as analyzed
above in MCMV-infected IFNAR/ mice that showed uncon-
trolled virus replication (Figures 6A and S2F). Moreover, by 21
dpi, bone marrow cellularity, LT-HSC numbers (Figures 6B
and S6C), and IFN-a levels in bone marrow and serum returned
to steady-state levels (Figure S6D). Intriguingly, increased levels
of IFN-g, IL-17, and CCL12 remained present until 21 dpi in the
bone marrow, but not in serum (Figures 6C and S6E). However,
despite this local inflammatory milieu, LT-HSCs as well as CPs
displayed a homeostatic cell cycle state (Figures 6D and S6F).
In contrast to MCMV infection, 21 dpi with VSV hi, the bone
marrow cytokine milieu and LT-HSC cell cycle state were indis-
tinguishable from PBS-treated controls (Figures S6G and S6H).
Accordingly, no reconstitution deficit was observed upon bone
marrow transplantation (Figure S6I), indicating a complete
remission of LT-HSC phenotype and function at later time
points following VSV infection.(E) Total blood chimerism post-transplantation from donors 21 dpi with MCMV
(n = 7–11; N = 2).
(F) Percentage CD45.2+ cells in lymphoid (B220+ and CD3+) and myeloid
(Ly6/G+ and CD11b+) lineages post-transplantation from (E) (n = 7–11; N = 2).
(G) Second transplant of bone marrow from mice from (E), blood chimerism
post-transplantation (n = 7–10; N = 2).
(H) Flow cytometry analysis (at indicated time points) of LSKCD135
CD150+CD34 HSCs for percentage (left panel) and absolute numbers (right
panel) of CD150lo lymphoid-biased and CD150hi myeloid-biased HSCs of
MCMV-infected WT mice (n = 5–7; N = 2). Error bars indicate mean ± SD;
significance was determined by two-sided t test (*p% 0.05, **p% 0.0025, and
***p % 0.0001; ns, not significant; n, biological replicates; N, experimental
repetitions).
See also Figure S4.
Figure 5. Intrinsic Impairment of LT-HSCs
Is the Cause of Reduced Reconstitution
Capacity following Acute and Non-acute
MCMV Infection
(A) Generation of competitive bone marrow chi-
meras with sorted LKCD150+CD48 HSCs and
experimental layout.
(B) CD45.2+ engraftment of individual mice from (A)
post-transplantation (dashed line: mean engraft-
ment at week 12) (n = 7–14; N = 2).
(C) Quantification of data from (B). Error bars indi-
cate mean ± SD; significance was determined by
two-sided t test (*p % 0.05, **p % 0.0025, and
***p % 0.0001; ns, not significant; n, biological
replicates; N, experimental repetitions).
See also Figure S5.Next, we investigated whether the inflammatory milieu
induced upon MCMV infection might be associated with gene
expression changes in HSCs. The qRT-PCR analyses of
selected IFN-I-stimulated genes (ISGs) in CPs and LKSLAM
HSCs of MCMV-infected WT mice revealed that ISG (Isg15
and Gbp6) expression was enhanced during the acute phase
(4 dpi), but it returned back to steady-state levels by 21 dpi. In
contrast, increased expression of stem cell antigen-1 (Sca-1)
was detected in HSCs 4 dpi, but it remained elevated until 21
dpi (Figure 6E, upper panel). The expression of the quiescence
enforcer Scl (Lacombe et al., 2010) was significantly reduced 4
dpi, but it returned to steady-state levels by 21 dpi (Figure 6E,
lower panel), in line with the observed transient cell cycle induc-
tion of LT-HSCs. An increased expression of the HSC regulator
Evi1 (Kataoka et al., 2011) was detected exclusively in HSCs
21 dpi (Figure 6E, lower panel). The changes in gene expression
of Isg15 and Evi1 were confirmed by single-cell qRT-PCR anal-
ysis of LKSLAM HSCs (Figure 6F) and verified by the analysis
of housekeeping gene expression (Figure S6J). In summary,
these results indicate that non-acute MCMV infection induces
a sustained inflammatory milieu in the bone marrow, even
when virus is absent from the hematopoietic system. This inflam-
matory milieu affects gene expression profiles in HSCs, and it is
associated with impaired HSC function upon transplantation.
DISCUSSION
In this study, we investigated the impact of virus-induced inflam-
matory responses on LT-HSC phenotype and function. WeCell Rfound that only high-dose VSV infection
activated LT-HSCs, while already moder-
ate doses of MCMV induced transient
bone marrow aplasia and LT-HSC activa-
tion. Upon all virus infections tested,
cytokine patterns detected in the bone
marrow differed significantly from those
detected in the blood. In transplantation
assays, bone marrow as well as HSCs
isolated 4 days (acute phase) and
21 days (non-acute phase) after MCMV
infection showed reduced capacity toreconstitute immune cells. Notably, HSCs returned to pheno-
typic quiescence during non-acuteMCMV infection, but they still
showed altered gene expression profiles and a reduced recon-
stitution capacity. These findings indicate that inflammatory re-
sponses that exceed certain threshold levels in the bone marrow
may induce LT-HSC activation and that a sustained inflamma-
tory response in the bone marrow can result in long-lasting
impairment of LT-HSC function (Figure 7).
An intermediate VSV dose did not induce LT-HSC activation in
WT but in IFNAR/ mice. This may be due to efficient virus
control in WT mice and unrestricted virus replication and highly
deregulated inflammatory responses in IFNAR/ mice (M€uller
et al., 1994). Nevertheless, high-dose VSV challenge of WT
mice efficiently activated LT-HSCs. Accordingly, MxCre+
Rosa26eYFPST/ST reporter mice showed direct IFNAR triggering
of LT-HSCs only upon high-, but not intermediate-dose VSV
infection. HSCs have been suggested to be activated either by
pulls (i.e., immune cell depletion) or pushes (i.e., inflammation)
(King and Goodell, 2011). Our results indicate that only VSV-
induced inflammatory responses resulting from either high-dose
virus infection (of WT mice) or uncontrolled viral replication (in
IFNAR/ mice) exceed threshold levels within the bone marrow
to efficiently push LT-HSCs into activation. Since frequent
LT-HSC activation leads to apoptosis and DNA damage (Pietras
et al., 2014; Walter et al., 2015), such an inflammatory threshold
assures that LT-HSCs are not activated too frequently, but rather
only when required, i.e., in the context of severe infections.
Interestingly, upon MCMV infection, LT-HSC activation was
more pronounced in WT than in IFNAR/mice. MCMV-inducedeports 19, 2345–2356, June 13, 2017 2351
Figure 6. Impairment of LT-HSCs during Non-acute MCMV Infection Is Associated with Sustained Changes in Both the Inflammatory Milieu
within the Bone Marrow as well as the LT-HSC Gene Expression Profile
(A) The qRT-PCR (at indicated time points) for the most abundant transcript (Mat) of MCMV in sorted CD45 bone marrow stroma cells, committed progenitors
(CPs), and LKSLAM HSCs (compare Figure S1A) of WT and IFNAR/ mice infected i.v. with 5 3 105 PFUs MCMV (n = 6; N = 2).
(B) Cell count of total bone marrow 4 and 21 dpi of WT mice infected i.v. with 5 3 105 PFUs MCMV (n = 8–11; N = 3).
(C) Heatmap of multiplex array for 22 cytokines and chemokines in blood sera and bonemarrow supernatants of mice from (B) (n = 3; N = 1). Data were normalized
to WT PBS controls.
(D) Intracellular Ki-67/Hoechst staining for quiescent (G0) and activated (G1-S-G2-M) LT-HSCs of MCMV-infected WT mice 4 and 21 dpi (n = 9–15; N = 3).
(E) qRT-PCR for interferon-stimulated genes (Isg) (upper panels) and stemness-associated genes (lower panels) in CPs and LKSLAM HSCs of MCMV-infected
WT mice 4 and 21 dpi (n = 6–10; N = 2).
(F) Single-cell qRT-PCR for Isg15 as well as Evi1 in sorted LKSLAM HSCs of MCMV-infected WTmice 4 and 21 dpi (n = 13–18; N = 1). Error bars indicate mean ±
SD; significance was determined by two-sided t test or two-way ANOVA (*p% 0.05, **p% 0.0025, and ***p% 0.0001; ns, not significant; n, biological replicates;
N, experimental repetitions).
See also Figure S6.
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Figure 7. Working Model for the Influence of Acute and Non-acute
Systemic Virus Infections on LT-HSC Phenotype and Function
If, during severe and acute virus infections, an inflammatory threshold is ex-
ceeded locally within the bone marrow, LT-HSCs show increased Isg levels,
decreased Scl expression, and a subsequent activation from quiescence. If
systemic infection is successfully cleared (i.e., VSV), LT-HSCs return to
quiescence and regain normal function. However, non-acute systemic in-
fections (i.e., MCMV) are capable of inducing a sustained inflammatory bone
marrow milieu. As a consequence, despite their phenotypic quiescence,
LT-HSCs display increased Sca-1 as well as Evi1 mRNA levels and functional
deficits (namely, decreased lymphoid output) upon transplantation.IFN-I responses were biologically active and directly triggered
HSCs, as indicated by enhanced YFP expression in bone
marrow cells of MCMV-infected MxCre+Rosa26eYFPST/ST re-
porter mice. Nevertheless, MCMV infection induced IFNAR-in-
dependent bone marrow aplasia, suggesting that cytokines
other than IFN-I also triggered inflammatory bone marrow re-
sponses. Taken together, these experiments indicate that, while
MCMV-induced LT-HSC activation can bemediated by other cy-
tokines, IFN-I still remains a critical factor. On the one hand,
particularly upon virus infections, IFN-I might push the inflamma-
tory response above thresholds required for LT-HSC activation.
On the other hand, IFNAR-independent LT-HSC activation may
assure that even viruses that efficiently inhibit IFN-I (Hoffmann
et al., 2015) still confer a hematopoietic push.
Of note, VSV and MCMV are two fundamentally different
viruses in terms of tropism, kinetics of infection, as well as mech-
anisms to induce and evade cytokine responses. In the presence
of IFN-I, one MCMV replication cycle takes several days (Dag
et al., 2014), explaining the delayed kinetics of MCMV-induced
LT-HSC activation compared with VSV infection.
VSV infection induced cytokine and chemokine responses
comprising IL-12(p40), IL-10, CCL2, CCL3, CCL4, and others,
as well as an increase of IL-10 receptor expression on
LT-HSCs. IL-12(p40) is produced by macrophages, neutro-
phils, and dendritic cells during inflammation (Hamza et al.,
2010). In contrast, IL-10 is an anti-inflammatory cytokine re-
ported to prevent immunopathology (de Vries, 1995) and to
promote HSC self-renewal (Kang et al., 2007). CCL2, CCL3,
and CCL4 are crucial for immune cell recruitment during
infections (Castellino et al., 2006; Deshmane et al., 2009).
Notably, also during MCMV infection, IL-12(p40), IL-10,
CCL2, CCL3, and CCL4 were detected within the bone
marrow. Thus, these mediators potentially confer LT-HSC
activation either via direct triggering or indirectly throughimmune cell recruitment and migration, even in the absence
of functional IFNAR signaling.
MCMV is able to establish persistent infection (Pollock et al.,
1997), and it has been reported to infect bone marrow stroma
in BALB/c mice (Reddehase et al., 1992). The MCMV variant
used in this study lacks the Ly49H ligand m157 (Arase et al.,
2002), thus evading initial NK cell control to establish productive
infection in C57BL/6 mice (Mitrovic et al., 2012). In our experi-
ments, in addition to the acute day 4 time point, we additionally
examinedWTmice in a non-acute setting 21 days after infection.
During non-acute MCMV infection, virus was detected in liver,
but not in bone marrow stroma, CPs, or LKSLAM HSCs (as
determined by plaque assay and Mat expression analysis).
Nevertheless, our data do not entirely exclude that very low
levels of viral genomes may continue to persist in hematopoietic
cells. Of note, CMV has been shown to directly interact with the
genomic region of the HSC self-renewal factor Satb1 (Lee et al.,
2007) and to prevent immune cell replenishment without directly
infecting HSCs (Mutter et al., 1988).
HSCs that are forced to exit from quiescence lose their long-
term reconstitution capability (Orford and Scadden, 2008).
Accordingly, bonemarrow as well as HSCs isolated during acute
MCMV infection showed severely impaired reconstitution in
competitive bone marrow transplantation experiments. Impor-
tantly, also bone marrow and HSCs isolated during non-acute
MCMV infection showed long-lasting, albeit transient, reconsti-
tution deficits that mainly affected the lymphoid lineage. Interest-
ingly, bone marrow analyzed during non-acute MCMV infection
contained an increased percentage of myeloid-biased HSCs. A
similar phenotype has previously been described as an aging-
associated bone marrow change (Beerman et al., 2010). This
suggests that aging andMCMV-induced sustained inflammation
have a comparable impact on HSC differentiation bias. Interest-
ingly, upon acute lymphocytic choriomeningitis virus (LCMV)
infection, reduced myeloid differentiation was detected (Matatall
et al., 2014), suggesting that, depending on the type of systemic
virus infection, HSC function might be influenced differently.
In contrast to MCMV infection, VSV is efficiently controlled by
IFN-I (M€uller et al., 1994). Accordingly, 21 dpi with VSV hi, an in-
flammatory milieu was no longer detected in the bone marrow
and LT-HSCs returned to quiescence. Furthermore, competitive
bone marrow transplantations from VSV-infected 21-dpi donors
showed normal reconstitution. This indicates that LT-HSCs may
recover phenotypically and functionally once a systemic virus
infection is entirely resolved.
Collectively, these findings may explain why in clinics bone
marrow grafts often do not confer efficient reconstitution or
even fail after an initial period of successful engraftment. Of
note, similarly to infections, vaccinations can trigger acute
inflammation that could potentially affect long-term hematopoi-
etic reconstitution of bone marrow transplants. This important
clinical aspect will have to be addressed experimentally in future
studies.
Since during non-acute MCMV infection LT-HSCs returned to
homeostatic cell cycle quiescence, we intended to analyze the
mechanism causing a sustained reconstitution impairment of
these cells. In accordance with their phenotypical quiescence
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levels of the quiescence enforcer Scl. Additionally, no bone
marrow IFN-a was detectable, and the expression of hallmark
ISGs (Isg15 and Gbp6) in CPs and HSCs waned to steady-state
levels. Nevertheless, 21 dpi a sustained inflammatory bone
marrow milieu with enhanced IFN-g, IL-17, and CCL12 levels
was detected. This could be attributable to cytokine secretion
by recirculating immune cells activated in peripheral lymphoid
tissues. Furthermore, increased Sca-1 mRNA levels were de-
tected in HSCs 21 dpi. Interestingly, IFN-g was shown to induce
Sca-1 expression in LT-HSCs (Holmes and Stanford, 2007) and,
moreover, to play a key role in LT-HSC activation during chronic
mycobacterial (Baldridge et al., 2010) and acute LCMV infection
(Matatall et al., 2014). Of note, in both bulk as well as single-cell
HSC analyses, we also found increased mRNA levels of Evi1, an
HSC master regulator (Kataoka et al., 2011). Evi1 was recently
described as a marker of acute myeloid leukemia (AML) and
chronic myeloid leukemia (CML) (Sato et al., 2014) and to be
associated with poor cancer prognosis (Jo et al., 2015). Taken
together, our results indicate that sustained MCMV-induced in-
flammatory responses within the bone marrow directly trigger
LT-HSCs and, thus, affect their transcriptional profile. Since
overexpression of Evi1 in HSCs was shown to deregulate several
genes that control cell division and cell self-renewal (Dickstein
et al., 2010), it is tempting to speculate that chronic inflammatory
stress may play a role in the genesis of cancer stem cells.
In conclusion, this study highlights that acute as well as non-
acute virus infections induce inflammatory responses within
the bone marrow that affect LT-HSC phenotype and function.
In these responses, IFN-I is an important, but not the only, crucial
factor that signals hematopoietic stress and activates quiescent
LT-HSCs. Following severe virus infections, HSCs show inflam-
mation-induced changes in gene expression that correlate with
impaired hematopoietic reconstitution and are sustained for
weeks during non-acute, subclinical infections. These results
imply that during subclinical infections of bone marrow donors,
inflammation-induced stress responses of LT-HSCsmight affect
their reconstitution potential, causing clinically relevant compli-
cations in transplant recipients.EXPERIMENTAL PROCEDURES
Mice, Viruses, and Other Stimuli
IFNAR/ mice (M€uller et al., 1994) were backcrossed more than 20 times on
the C57BL/6 background. MxCre+Rosa26eYFPST/ST mice were generated by
crossingMxCre+ (K€uhn et al., 1995) and Rosa26eYFPST/ST mice (Srinivas et al.,
2001). C57BL/6 mice were purchased from Harlan Winkelmann. Mice were
bred under specific pathogen-free, Federation for Laboratory Animal Science
Associations (FELASA) conditions at Twincore and the Helmholtz-Centre for
Infection Research (HZI). Experiments were performed with female mice be-
tween 10 and 16 weeks of age and in compliance with German animal welfare
regulations supervised by the Lower Saxony State Office for Consumer Pro-
duction and Food Safety (LAVES). VSV-M2 (VSV) (Stojdl et al., 2003) was kindly
provided by John Bell (University of Ottawa). MCMV-Dm157 (MCMV) (Jordan
et al., 2011) was provided by Stefan Jordan (Icahn School of Medicine). High-
molecular-weight poly(I:C) HMW (Sigma) was administered at 10 mg/g body
weight per mouse. All stimuli were intravenously (i.v.) administered in PBS.
Cell Isolation and Flow Cytometry
Bone marrow cells were isolated by crushing hind leg bones and (if required)
spinal cord in cold RPMI medium, and they were treated with red blood cell2354 Cell Reports 19, 2345–2356, June 13, 2017lysis buffer (Sigma). Bone marrow was stained with anti-CD135-PE
monoclonal antibody (mAb) or anti-CD48-PE mAb (both eBiosciences), or
anti-IL-10R-PE mAb (or corresponding isotype control) (BioLegend), anti-
CD34-AF700 mAb (eBiosciences), anti-CD150-PE-Cy5 mAb, anti-Sca-1-PE-
Cy7 mAb, anti-c-Kit-APC-Cy7 mAb (all BioLegend), and anti-lineage-APC
(BD Pharmingen). For proliferation staining, cells were permeabilized with
Cytofix/Cytoperm and stained with anti-Ki-67-FITC mAb, corresponding iso-
type control (all BD Pharmingen), and Hoechst 33342 nucleic acid stain
(from Life Technologies).
Blood was stained with anti-B220-PacBlue mAb, anti-CD11b-APC-Cy7
mAb (both BD Pharmingen), anti-Ly6/G-PE-Cy7 mAb (BioLegend), and anti-
CD3-AF647 mAb (Caltaq) and treated with red blood cell lysing solution (BD
Pharmingen).
Unspecific Fc-receptor binding was blocked by anti-CD16/CD32-unconju-
gated mAb (BD Pharmingen) prior to surface staining.
Cell counts were determined using AccuCheck counting beads (Life
Technologies).
Cells were measured by flow cytometry (FACS) (LSR II Sorb; Becton Dick-
inson), and data were analyzed with the FlowJo software.
Cell Sorting
After bone marrow isolation, cells were lineage depleted by AutoMACS-based
magnetic separation using a mouse lineage depletion kit (Miltenyi Biotech).
Cells were stained with anti-CD48-PE mAb (eBioscience), anti-c-Kit-APC-
Cy7 mAb, anti-CD150-PE-Cy5 mAb, and anti-lineage-PacBlue (BioLegend).
Cells were sorted using a MoFlo XDP (Beckman Coulter) or Aria II (Beckton
Dickinson) cell sorter.
Bone Marrow Chimeras
For 1:1 competitive bone marrow chimeras, 5 3 105 bone marrow cells from
PBS- or virus-treated CD45.2+ WT donors were mixed with 5 3 105 bone
marrow cells from CD45.1+ naive congenic WT donors. The 1 3 106 mixture
cells were i.v. transplanted into lethally irradiated (10 Gy X-ray, 3-hr split
dose) congenic CD45.1+ WT recipients.
For 1:1,000 competitive HSC chimeras, 500 sorted LKSLAM HSCs from
PBS- or virus-treated CD45.2+ WT donors were mixed with 5 3 105 bone
marrow cells from CD45.1+ naive congenic WT donors. The 5 3 105 mixture
cells were i.v. transplanted into lethally irradiated congenic CD45.1+ WT recip-
ients. Chimerismwas determined by flow cytometry staining with anti-CD45.1-
FITC mAb (BD Pharmingen) and anti-CD45.2-PacBlue mAb (BioLegend).
Bone Marrow Supernatants
Hindleg bones were crushed in 500 mL cold RPMI medium, and suspensions
were high-speed centrifuged in blood serum tubes to separate cellular
components.
Cytokine and Chemokine Analyses
Serum and bone marrow supernatants were tested for IFN-a using the
VeriKine kit (PBL Assay Science) and for IFN-g using the Ready-SET-Go! kit
(eBioscience), following the manufacturers’ instructions. Multiplex cytokine
array was performed using the Bio-Plex Pro Mouse Cytokine 23-Plex Assay
(Bio-Rad), following the manufacturer’s instructions. Heatmaps were gener-
ated from average values of each parameter using The R Project for Statistical
Computing software.
Plaque Assays
Organ homogenates were plated in serial log10 dilutions on Vero cells for 1 day
(VSV) or on mouse embryonic fibroblasts for 6–7 days (MCMV), with a 1%
methyl-cellulose overlay. Plaques were counted following staining with crystal
violet (Merck).
Real-Time qPCR
For bulk analyses, 5,000–15,000 CPs or HSCs were sorted into lysis buffer,
and RNA was extracted using the Arcturus PicoPure kit (Applied Biosystems),
according to the manufacturer’s instructions. Subsequently, RNA was
reverse-transcribed to cDNA using the PrimeScript Kit (Takara Clonetech).
RT-PCRs were carried out in technical triplicates using Power SYBR Green
(Applied Biosystems), and they were run on a ViiATM 7 Real-Time PCR system
(Applied Biosystems). Expression values were calculated using the DDCT
method with Sdha, Oaz1, and Actb as endogenous control genes. Single-
cell qRT-PCR experiments and analyses were performed as previously
described (Haas et al., 2015). Primers for the respective experiments are listed
in Table S1.
Statistical Analysis
Statistical significance was determined by two-sided t test or, for multiple data
comparisons, by two-way ANOVAwith Bonferroni correction. The p values are
as follows: *p% 0.05, **p% 0.0025, and ***p% 0.0001. The number of biolog-
ical replicates (n) and experimental repetitions (N) is indicated in each figure
legend. All statistical analyses were performed using the GraphPad Prism
7 software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.celrep.2017.05.063.
AUTHOR CONTRIBUTIONS
C.H., S.F.H., T.F., M.A.G.E., and U.K. conceived experiments. C.H., S.F.H.,
M.D., T.F., P-K.T., K.B., C.C., E.P., and S.L. performed experiments. C.H.,
T.F., S.F.H., and U.K. wrote the manuscript. U.K., M.A.G.E., and A.T. secured
funding. S. Jordan provided reagents. C.S.F., I.B., K.K., M.M., S. Jonjic, and S.
Jordan provided expertise and feedback.
ACKNOWLEDGMENTS
We thank Matthias Ballmaier, Christina Struckmann, Marcus Eich, and Klaus
Hexel for cell sorting, as well as Nadine Thiel, Vanda Juranic Lisnic, and Fran-
ziska Pilz for assistance with MCMV assays. This study was supported by
funding from the Helmholtz Virtual Institute (VH-VI-424 Viral Strategies of Im-
mune Evasion) to M.M., S. Jordan, and U.K., by funding from the Niedersach-
sen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Sci-
ence and Culture of Lower Saxony, Germany, to U.K., and by funding from the
Hannover Biomedical Research School (HBRS) and the Centre for Infection
Biology (ZIB) to C.H. S.L. was supported by a travel grant of the REBIRTH
Cluster of Excellence, Hannover.
Received: March 3, 2016
Revised: April 25, 2017
Accepted: May 18, 2017
Published: June 13, 2017
REFERENCES
Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B., and Lanier, L.L. (2002).
Direct recognition of cytomegalovirus by activating and inhibitory NK cell re-
ceptors. Science 296, 1323–1326.
Baldridge, M.T., King, K.Y., Boles, N.C., Weksberg, D.C., and Goodell, M.A.
(2010). Quiescent haematopoietic stem cells are activated by IFN-gamma in
response to chronic infection. Nature 465, 793–797.
Beerman, I., Bhattacharya, D., Zandi, S., Sigvardsson, M., Weissman, I.L.,
Bryder, D., and Rossi, D.J. (2010). Functionally distinct hematopoietic stem
cells modulate hematopoietic lineage potential during aging by a mechanism
of clonal expansion. Proc. Natl. Acad. Sci. USA 107, 5465–5470.
Boeckh, M., and Nichols, W.G. (2004). The impact of cytomegalovirus seros-
tatus of donor and recipient before hematopoietic stem cell transplantation in
the era of antiviral prophylaxis and preemptive therapy. Blood 103, 2003–2008.
Cabezas-Wallscheid, N., Klimmeck, D., Hansson, J., Lipka, D.B., Reyes, A.,
Wang, Q., Weichenhan, D., Lier, A., von Paleske, L., Renders, S., et al.
(2014). Identification of regulatory networks in HSCs and their immediate prog-
eny via integrated proteome, transcriptome, and DNA methylome analysis.
Cell Stem Cell 15, 507–522.Castellino, F., Huang, A.Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C., and
Germain, R.N. (2006). Chemokines enhance immunity by guiding naive
CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440,
890–895.
Crouse, J., Kalinke, U., and Oxenius, A. (2015). Regulation of antiviral T cell re-
sponses by type I interferons. Nat. Rev. Immunol. 15, 231–242.
Dag, F., Do¨lken, L., Holzki, J., Drabig, A., Weinga¨rtner, A., Schwerk, J., Lienen-
klaus, S., Conte, I., Geffers, R., Davenport, C., et al. (2014). Reversible
silencing of cytomegalovirus genomes by type I interferon governs virus la-
tency. PLoS Pathog. 10, e1003962.
de Vries, J.E. (1995). Immunosuppressive and anti-inflammatory properties of
interleukin 10. Ann. Med. 27, 537–541.
Deshmane, S.L., Kremlev, S., Amini, S., and Sawaya, B.E. (2009). Monocyte
chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res.
29, 313–326.
Dickstein, J., Senyuk, V., Premanand, K., Laricchia-Robbio, L., Xu, P., Catta-
neo, F., Fazzina, R., and Nucifora, G. (2010). Methylation and silencing of
miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells
in murine myelodysplastic syndrome. Proc. Natl. Acad. Sci. USA 107, 9783–
9788.
Essers, M.A., Offner, S., Blanco-Bose, W.E., Waibler, Z., Kalinke, U., Duch-
osal, M.A., and Trumpp, A. (2009). IFNalpha activates dormant haematopoietic
stem cells in vivo. Nature 458, 904–908.
Fries, B.C., Riddell, S.R., Kim, H.W., Corey, L., Dahlgren, C., Woolfrey, A., and
Boeckh, M. (2005). Cytomegalovirus disease before hematopoietic cell trans-
plantation as a risk for complications after transplantation. Biol. Blood Marrow
Transplant. 11, 136–148.
Haas, S., Hansson, J., Klimmeck, D., Loeffler, D., Velten, L., Uckelmann, H.,
Wurzer, S., Prendergast, A.M., Schnell, A., Hexel, K., et al. (2015). Inflamma-
tion-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem
Cell-like Megakaryocyte Progenitors. Cell Stem Cell 17, 422–434.
Hamza, T., Barnett, J.B., and Li, B. (2010). Interleukin 12 a key immunoregula-
tory cytokine in infection applications. Int. J. Mol. Sci. 11, 789–806.
Hoffmann, H.H., Schneider, W.M., and Rice, C.M. (2015). Interferons and
viruses: an evolutionary arms race of molecular interactions. Trends Immunol.
36, 124–138.
Holmes, C., and Stanford, W.L. (2007). Concise review: stem cell antigen-1:
expression, function, and enigma. Stem Cells 25, 1339–1347.
Jo, A., Mitani, S., Shiba, N., Hayashi, Y., Hara, Y., Takahashi, H., Tsukimoto, I.,
Tawa, A., Horibe, K., Tomizawa, D., et al. (2015). High expression of EVI1 and
MEL1 is a compelling poor prognostic marker of pediatric AML. Leukemia 29,
1076–1083.
Jordan, S., Krause, J., Prager, A., Mitrovic, M., Jonjic, S., Koszinowski, U.H.,
and Adler, B. (2011). Virus progeny of murine cytomegalovirus bacterial artifi-
cial chromosome pSM3fr show reduced growth in salivary Glands due to a
fixed mutation of MCK-2. J. Virol. 85, 10346–10353.
Juranic Lisnic, V., Babic Cac, M., Lisnic, B., Trsan, T., Mefferd, A., DasMukho-
padhyay, C., Cook, C.H., Jonjic, S., and Trgovcich, J. (2013). Dual analysis of
the murine cytomegalovirus and host cell transcriptomes reveal new aspects
of the virus-host cell interface. PLoS Pathog. 9, e1003611.
Kang, Y.J., Yang, S.J., Park, G., Cho, B., Min, C.K., Kim, T.Y., Lee, J.S., and
Oh, I.H. (2007). A novel function of interleukin-10 promoting self-renewal of he-
matopoietic stem cells. Stem Cells 25, 1814–1822.
Kataoka, K., Sato, T., Yoshimi, A., Goyama, S., Tsuruta, T., Kobayashi, H., Shi-
mabe, M., Arai, S., Nakagawa, M., Imai, Y., et al. (2011). Evi1 is essential for
hematopoietic stem cell self-renewal, and its expression marks hematopoietic
cells with long-termmultilineage repopulating activity. J. Exp. Med. 208, 2403–
2416.
Kiel, M.J., Yilmaz, O.H., Iwashita, T., Yilmaz, O.H., Terhorst, C., and Morrison,
S.J. (2005). SLAM family receptors distinguish hematopoietic stem and pro-
genitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121.Cell Reports 19, 2345–2356, June 13, 2017 2355
King, K.Y., and Goodell, M.A. (2011). Inflammatory modulation of HSCs:
viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol.
11, 685–692.
K€uhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995). Inducible gene tar-
geting in mice. Science 269, 1427–1429.
Lacombe, J., Herblot, S., Rojas-Sutterlin, S., Haman, A., Barakat, S., Iscove,
N.N., Sauvageau, G., and Hoang, T. (2010). Scl regulates the quiescence
and the long-term competence of hematopoietic stem cells. Blood 115,
792–803.
Lee, J., Klase, Z., Gao, X., Caldwell, J.S., Stinski, M.F., Kashanchi, F., and
Chao, S.H. (2007). Cellular homeoproteins, SATB1 and CDP, bind to the
unique region between the human cytomegalovirus UL127 and major immedi-
ate-early genes. Virology 366, 117–125.
Matatall, K.A., Shen, C.C., Challen, G.A., and King, K.Y. (2014). Type II inter-
feron promotes differentiation of myeloid-biased hematopoietic stem cells.
Stem Cells 32, 3023–3030.
Mitrovic, M., Arapovic, J., Jordan, S., Fodil-Cornu, N., Ebert, S., Vidal, S.M.,
Krmpotic, A., Reddehase, M.J., and Jonjic, S. (2012). The NK cell response
to mouse cytomegalovirus infection affects the level and kinetics of the early
CD8(+) T-cell response. J. Virol. 86, 2165–2175.
Morrison, S.J., and Scadden, D.T. (2014). The bone marrow niche for haema-
topoietic stem cells. Nature 505, 327–334.
Morrison, S.J., and Weissman, I.L. (1994). The long-term repopulating subset
of hematopoietic stem cells is deterministic and isolatable by phenotype. Im-
munity 1, 661–673.
M€uller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R.M.,
and Aguet, M. (1994). Functional role of type I and type II interferons in antiviral
defense. Science 264, 1918–1921.
Mutter, W., Reddehase, M.J., Busch, F.W., B€uhring, H.J., and Koszinowski,
U.H. (1988). Failure in generating hemopoietic stem cells is the primary cause
of death from cytomegalovirus disease in the immunocompromised host.
J. Exp. Med. 167, 1645–1658.
Nagai, Y., Garrett, K.P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., Takatsu, K.,
and Kincade, P.W. (2006). Toll-like receptors on hematopoietic progenitor
cells stimulate innate immune system replenishment. Immunity 24, 801–812.
Orford, K.W., and Scadden, D.T. (2008). Deconstructing stem cell self-
renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9,
115–128.
Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996). Long-term lym-
phohematopoietic reconstitution by a single CD34-low/negative hematopoiet-
ic stem cell. Science 273, 242–245.2356 Cell Reports 19, 2345–2356, June 13, 2017Pietras, E.M., Lakshminarasimhan, R., Techner, J.M., Fong, S., Flach, J., Bin-
newies, M., and Passegue´, E. (2014). Re-entry into quiescence protects
hematopoietic stem cells from the killing effect of chronic exposure to type I
interferons. J. Exp. Med. 211, 245–262.
Pollock, J.L., Presti, R.M., Paetzold, S., and Virgin, H.W., 4th. (1997). Latent
murine cytomegalovirus infection in macrophages. Virology 227, 168–179.
Reddehase, M.J., Dreher-Stumpp, L., Angele, P., Balthesen, M., and Susa, M.
(1992). Hematopoietic stem cell deficiency resulting from cytomegalovirus
infection of bone marrow stroma. Ann. Hematol. 64 (Suppl), A125–A127.
Sato, T., Goyama, S., Kataoka, K., Nasu, R., Tsuruta-Kishino, T., Kagoya, Y.,
Nukina, A., Kumagai, K., Kubota, N., Nakagawa, M., et al. (2014). Evi1 defines
leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic
myeloid leukemia. Oncogene 33, 5028–5038.
Srinivas, S., Watanabe, T., Lin, C.S., William, C.M., Tanabe, Y., Jessell, T.M.,
and Costantini, F. (2001). Cre reporter strains produced by targeted insertion
of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4.
Stojdl, D.F., Lichty, B.D., tenOever, B.R., Paterson, J.M., Power, A.T.,
Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., et al. (2003).
VSV strains with defects in their ability to shutdown innate immunity are potent
systemic anti-cancer agents. Cancer Cell 4, 263–275.
Takizawa, H., Regoes, R.R., Boddupalli, C.S., Bonhoeffer, S., and Manz, M.G.
(2011). Dynamic variation in cycling of hematopoietic stem cells in steady state
and inflammation. J. Exp. Med. 208, 273–284.
Waibler, Z., Detje, C.N., Bell, J.C., and Kalinke, U. (2007). Matrix protein medi-
ated shutdown of host cell metabolism limits vesicular stomatitis virus-induced
interferon-alpha responses to plasmacytoid dendritic cells. Immunobiology
212, 887–894.
Walter, D., Lier, A., Geiselhart, A., Thalheimer, F.B., Huntscha, S., Sobotta,
M.C., Moehrle, B., Brocks, D., Bayindir, I., Kaschutnig, P., et al. (2015). Exit
from dormancy provokes DNA-damage-induced attrition in haematopoietic
stem cells. Nature 520, 549–552.
Wilson, A., Oser, G.M., Jaworski, M., Blanco-Bose, W.E., Laurenti, E., Adol-
phe, C., Essers, M.A., Macdonald, H.R., and Trumpp, A. (2007). Dormant
and self-renewing hematopoietic stem cells and their niches. Ann. N Y Acad.
Sci. 1106, 64–75.
Wilson, A., Laurenti, E., Oser, G., van derWath, R.C., Blanco-Bose, W., Jawor-
ski, M., Offner, S., Dunant, C.F., Eshkind, L., Bockamp, E., et al. (2008). He-
matopoietic stem cells reversibly switch from dormancy to self-renewal during
homeostasis and repair. Cell 135, 1118–1129.
